Endpoints News Mar 6, 2026 Pfizer gets obesity drug approval in China shortly after buying local rights
Endpoints News Feb 24, 2026 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News Feb 7, 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News Jan 8, 2026 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News Dec 5, 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News Dec 4, 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen